Avita Medical (RCEL)

Avita Medical (RCEL) Stock Price & Analysis


RCEL Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$6.29 - $21.70
Previous Close$11.24
Average Volume (3M)186.48K
Market Cap
Enterprise Value$214.10M
Total Cash (Recent Filing)$60.12M
Total Debt (Recent Filing)$1.84M
Price to Earnings (P/E)-8.4
Feb 22, 2024
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.33
Shares Outstanding25,550,694
10 Day Avg. Volume209,612
30 Day Avg. Volume186,481
Standard Deviation0.24
Financial Highlights & Ratios
Price to Book (P/B)4.36
Price to Sales (P/S)8.34
Price to Cash Flow (P/CF)-7.60
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue5.96
Enterprise Value/Gross Profit7.54
Enterprise Value/Ebitda-8.11
Price Target Upside117.97% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6



Ownership Overview

10.92% Mutual Funds
16.32% Other Institutional Investors
72.76% Public Companies and
Individual Investors


What was Avita Medical’s price range in the past 12 months?
Avita Medical lowest stock price was $6.29 and its highest was $21.70 in the past 12 months.
    What is Avita Medical’s market cap?
    Currently, no data Available
    When is Avita Medical’s upcoming earnings report date?
    Avita Medical’s upcoming earnings report date is Feb 22, 2024 which is in 81 days.
      How were Avita Medical’s earnings last quarter?
      Avita Medical released its earnings results on Nov 09, 2023. The company reported -$0.34 earnings per share for the quarter, beating the consensus estimate of -$0.435 by $0.095.
        Is Avita Medical overvalued?
        According to Wall Street analysts Avita Medical’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Avita Medical pay dividends?
          Avita Medical does not currently pay dividends.
          What is Avita Medical’s EPS estimate?
          Avita Medical’s EPS estimate is -$0.37.
            How many shares outstanding does Avita Medical have?
            Avita Medical has 25,550,694 shares outstanding.
              What happened to Avita Medical’s price movement after its last earnings report?
              Avita Medical reported an EPS of -$0.34 in its last earnings report, beating expectations of -$0.435. Following the earnings report the stock price went up 14.271%.
                Which hedge fund is a major shareholder of Avita Medical?
                Among the largest hedge funds holding Avita Medical’s share is Driehaus Capital Management LLC. It holds Avita Medical’s shares valued at 7M.


                  Company Description

                  Avita Medical

                  Avita Medical Ltd. engages in the development and distribution of regenerative and respiratory medicine and treatments. It operates through the following segments: Asia Pacific, Europe, and Americas. The Asia Pacific, Europe, and Americas segments involve in the sale of RECELL Devices. The company was founded on December 21, 1992 and is headquartered in Royston, the United Kingdom.


                  Top 5 ETFs holding RCEL

                  Market Value
                  Smart Score
                  Vanguard Total Stock Market ETF
                  iShares Core S&P Total U.S. Stock Market ETF
                  iShares Russell 3000 ETF
                  Dimensional U.S. Equity ETF
                  Vanguard Russell 3000 ETF
                  Up to five ETFs with an Outperform Smart Score that hold RCEL. The ETFs are listed according to market value of RCEL within the ETF

                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  NovaBay Pharma

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis